COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03802058
Recruitment Status : Recruiting
First Posted : January 14, 2019
Last Update Posted : April 25, 2019
CSPC Ouyi Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Conghua Xie,MD,PhD, Wuhan University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 6, 2022
Estimated Study Completion Date : November 6, 2022